Lupus is a chronic autoimmune disease in which the immune system mistakenly attacks healthy tissues. It can affect the joints, skin, kidneys, blood cells, lungs, heart, and nervous system. Because lupus affects people differently, treatment is usually personalized according to the organs involved and how active the disease is.
For many years, lupus treatment mainly relied on medicines such as hydroxychloroquine, corticosteroids, immunosuppressants, and other targeted medicines. Today, biologic therapy for lupus has become an important treatment option for selected patients.
But who can benefit from biologic medicines? Are they suitable for everyone with lupus? And how do they work?
Let us understand the role of biologic therapy in lupus, when it may be considered, and what patients should know before starting treatment.
What Is Biologic Therapy for Lupus?
Biologic medicines are treatments made using biological sources and designed to target specific parts of the immune system.
Unlike medicines that broadly suppress immune activity, biologics are designed to interfere with particular immune pathways involved in inflammation and autoimmune disease.
In lupus, abnormal immune activity can lead to the production of autoantibodies and inflammation that damages healthy tissues. Some biologic medicines target specific immune signals or cells involved in this process.
Biologic therapy may therefore help control lupus activity in patients who do not achieve adequate disease control with standard treatments.
Which Biologic Medicines Are Used for Lupus?
Two biologic therapies are particularly important in lupus treatment:
1. Belimumab
Belimumab is a biologic medicine that targets B-cell activating factor (BAFF), also known as BLyS.
B cells are immune cells involved in antibody production. In lupus, abnormal B-cell activity can contribute to the production of autoantibodies.
By reducing the activity of this pathway, belimumab can help reduce lupus disease activity in selected patients.
It may be used for certain people with:
- Active systemic lupus erythematosus
- Autoantibody-positive lupus
- Lupus that remains active despite standard treatment
- Certain patients with active lupus nephritis, alongside other treatment
Belimumab can be given through intravenous infusion or, depending on the situation and formulation, as a subcutaneous injection.
2. Anifrolumab
Anifrolumab is another biologic medicine used for certain adults with moderate-to-severe systemic lupus erythematosus.
It targets the type I interferon receptor. Type I interferon pathways are involved in immune activation in many people with lupus.
By blocking this pathway, anifrolumab can help reduce disease activity, particularly in patients with active non-renal lupus.
Anifrolumab is administered by intravenous infusion.
Who Can Benefit from Biologic Therapy for Lupus?
Biologic therapy is not automatically required for everyone with lupus.
It may be considered when lupus remains active despite appropriate standard treatment or when reducing steroid exposure is an important treatment goal.
A rheumatologist may consider biologic therapy for patients who have:
Persistent Active Lupus
Some patients continue to experience joint inflammation, skin disease, fatigue, or other lupus manifestations even after receiving standard treatment.
If disease activity remains significant, a biologic may be considered as part of a treatment strategy.
Repeated Lupus Flares
Frequent disease flares can affect quality of life and may increase the risk of long-term organ damage.
For selected patients with recurrent flares despite conventional treatment, biologic therapy may help achieve better disease control.
Difficulty Reducing Steroids
Corticosteroids can be very effective in controlling lupus inflammation. However, long-term or high-dose steroid use can cause significant side effects.
Biologic therapy may sometimes be used as part of a steroid-sparing strategy, allowing the treatment team to reduce steroid exposure when disease control permits.
Inadequate Response to Standard Treatment
Lupus treatment may involve hydroxychloroquine, corticosteroids, mycophenolate, methotrexate, azathioprine, cyclophosphamide, calcineurin inhibitors, or other medicines depending on the organs affected.
If appropriate treatment does not adequately control the disease, targeted biologic therapy may be considered.
Certain Patients With Lupus Nephritis
Lupus nephritis occurs when lupus affects the kidneys.
Kidney involvement requires careful treatment because uncontrolled inflammation can lead to permanent kidney damage.
Belimumab may be used in selected patients with active lupus nephritis in combination with standard therapy. It is not a replacement for the complete lupus nephritis treatment plan.
The choice depends on kidney function, biopsy findings, disease activity, previous treatment, and other individual factors.
Can Biologics Be Used for Every Lupus Patient?
No.
Lupus is a highly variable disease, and biologic therapy is not necessary for every patient.
Someone with mild, well-controlled lupus may not need a biologic.
For example, a patient whose symptoms are adequately controlled with hydroxychloroquine and other appropriate treatment may continue with that approach under medical supervision.
Biologics are generally considered when there is a specific clinical reason to use them.
The decision depends on:
- Type and severity of lupus
- Organs affected
- Current disease activity
- Previous treatments
- Response to treatment
- History of lupus flares
- Infection risk
- Other medical conditions
- Pregnancy or pregnancy plans
- Overall treatment goals
What Are the Benefits of Biologic Therapy?
For appropriately selected patients, biologic therapy may provide several potential benefits.
Better Disease Control
Targeting specific immune pathways may help reduce inflammation and lupus activity.
Fewer Flares
Controlling disease activity can potentially reduce the frequency or severity of lupus flares in suitable patients.
Reduced Steroid Dependence
One important treatment goal in modern lupus care is to control disease while minimizing unnecessary long-term corticosteroid exposure.
Improved Quality of Life
Better control of active lupus symptoms may help patients manage daily activities, work, exercise, and other aspects of life more comfortably.
However, results vary from person to person. A biologic medicine should not be considered a guaranteed solution or a cure for lupus.
How Long Does Biologic Therapy Take to Work?
Biologic medicines do not necessarily produce immediate improvement.
Some patients may notice improvement over the first few months, while others may take longer to respond.
Doctors usually monitor:
- Joint symptoms
- Skin manifestations
- Fatigue and general symptoms
- Blood test results
- Disease activity
- Kidney parameters when relevant
- Frequency of flares
- Medication side effects
If the expected response is not achieved, the rheumatologist may reassess the diagnosis, disease activity, treatment adherence, or the need for a different treatment approach.
Are Biologic Medicines Safe?
Biologic therapies can be appropriate and effective for selected patients, but they can also have side effects.
Because biologics affect the immune system, infection risk is an important consideration.
Possible side effects can vary depending on the medicine and may include:
- Infusion-related reactions
- Headache
- Nausea
- Upper respiratory infections
- Viral infections
- Fever
- Injection-site reactions with injectable treatments
Rare but serious complications can occur.
Before starting treatment, the doctor may review vaccination history, infection risks, previous infections, and other medicines.
Patients should inform their doctor if they develop symptoms such as persistent fever, severe cough, unusual infections, or other concerning symptoms while receiving biologic treatment.
What Tests May Be Needed Before Starting a Biologic?
Before prescribing a biologic, the doctor may evaluate the patient’s overall health and lupus activity.
Depending on the medicine and individual circumstances, evaluation may include:
- Complete blood count
- Kidney and liver function tests
- Urine testing
- Lupus disease activity assessment
- Autoantibody testing when clinically relevant
- Infection screening
- Vaccination review
The exact tests are not the same for every patient.
Biologic Therapy and Pregnancy
Pregnancy planning is particularly important in lupus because some lupus medicines are not suitable during pregnancy.
If you are pregnant, planning pregnancy, or breastfeeding, tell your rheumatologist before starting or changing any lupus medicine.
The treatment plan may need to be adjusted according to disease activity, pregnancy stage, previous organ involvement, and medication safety.
Do not stop a biologic or any other lupus medicine on your own.
Is Biologic Therapy a Cure for Lupus?
No.
Biologic therapy is not a cure for lupus.
Lupus is a chronic autoimmune condition, and treatment aims to control disease activity, prevent flares, protect organs, and maintain a good quality of life.
Some patients can achieve remission or very low disease activity with appropriate treatment. However, ongoing monitoring is usually necessary even when symptoms improve.
Biologic Therapy vs Traditional Lupus Treatment
It is important not to think of biologics as a replacement for all other lupus medicines.
Lupus treatment is often a combination of approaches.
For example, a patient may continue hydroxychloroquine or another appropriate medicine while receiving a biologic. In lupus nephritis, biologic therapy may be added to other kidney-protective and immunosuppressive treatments when appropriate.
The goal is to create the right treatment combination for the individual patient, rather than simply using the newest medicine.
When Should You Ask Your Rheumatologist About Biologic Therapy?
You may want to discuss biologic therapy if:
- Your lupus remains active despite treatment.
- You are experiencing repeated flares.
- Your doctor is finding it difficult to reduce corticosteroids.
- You have persistent joint or skin symptoms.
- Your lupus is affecting your daily activities despite treatment.
- You have lupus nephritis and need an individualized treatment strategy.
- You have had inadequate responses or intolerance to previous treatments.
Your rheumatologist can determine whether a biologic is appropriate after reviewing your disease activity, organ involvement, previous medications, and overall health.
Frequently Asked Questions
1. Is biologic therapy necessary for everyone with lupus?
No. Many people with lupus can achieve good disease control without biologic therapy. Biologics are considered for selected patients based on disease activity, organ involvement, previous treatment response, and other factors.
2. Are biologics better than steroids for lupus?
Biologics and steroids have different roles. Steroids can control inflammation quickly, while biologics target specific immune pathways. In some patients, biologics may help reduce the need for prolonged steroid treatment.
3. Can biologics treat lupus nephritis?
Certain biologic therapies, particularly belimumab, may be used in selected patients with active lupus nephritis along with standard treatment. The choice depends on the individual’s kidney disease and overall clinical situation.
4. How long can I take biologic therapy?
There is no single treatment duration for everyone. The duration depends on disease control, response, side effects, and the ongoing assessment of the treating rheumatologist.
5. Can I stop my other lupus medicines after starting a biologic?
Not necessarily. Biologics are often used together with other lupus treatments. Never stop hydroxychloroquine, steroids, immunosuppressants, or biologics without discussing it with your doctor.
6. Do biologics completely stop lupus flares?
No medicine can guarantee that flares will never occur. The goal is to achieve sustained disease control and reduce the risk of future flares and organ damage.
7. What happens if a biologic does not work?
Your rheumatologist may reassess disease activity, treatment adherence, side effects, and the diagnosis. Depending on the situation, another treatment strategy may be considered.
Final Takeaway
Biologic therapy for lupus can be an important treatment option for selected patients with active disease, recurrent flares, inadequate response to standard treatment, or difficulty reducing steroid exposure.
Medicines such as belimumab and anifrolumab target specific pathways involved in lupus-related immune activity. However, they are not suitable for every patient and are not a cure for lupus.
The most important step is individualized treatment. If your lupus remains active despite your current medicines, speak with a rheumatologist about whether targeted or biologic therapy could be appropriate for you. Early treatment, regular monitoring, and careful control of disease activity can help protect organs and support a better long-term quality of life.
